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Abstract
The Republic of Serbia is a country with ongoing endemic transmission of measles. The aim
of this study is to summarize the main characteristics of the measles resurgence that
occurred in Serbia in 2014–2015. The national surveillance data on measles was analysed
in relation to the clinical, epidemiological and laboratory data. Between November 2014 and
December 2015 a measles resurgence with 420 cases was observed in Serbia. Measles
virus was initially introduced by and spread among citizens of Bosnia and Herzegovina with
temporary residence in Serbia, before spreading to the resident population. Of the 223
patients with available medical records, 173 (77.6%) were unvaccinated. The overall mea-
sles incidence during the outbreak was 5.8/100.000. The highest age-specific incidence
rate was recorded in children aged�4 years (25.9/100.000), but most cases (67.9%) were
�20 years old. Hospitalization rate was high (32.9%) and included two cases of encephalitis
associated with measles. In total, 42 health-care workers and 22 related cases including
hospitalized patients (n = 13) contracted measles. The overall percentage of laboratory con-
firmed cases was 81.7% (n = 343/420). All measles virus sequences except one (D9)
belonged to genotype D8, suggesting interruption of transmission after the previous out-
break in 2010–2011 caused by genotype D4 viruses. The growing number of adult patients
as compared to previous epidemics, suggests an urgent need for supplementary immuniza-
tion activities targeting susceptible health care workers, unvaccinated or incompletely
vaccinated adults as well as people without vaccination records. The comprehensive inves-
tigation of the 2014/2015 measles resurgence will contribute to decisions about appropriate
countermeasures to stop the future measles resurgences in Serbia.
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Introduction
Despite the availability of vaccine for more than 50 years, measles still remains one of the lead-
ing causes of global child mortality [1,2]. Elimination of measles in the European Region of the
World Health Organization (WHO) targeted for 2015 was not achieved [3,4], leading to the
adoption of the Global Measles and Rubella Strategic Plan, 2012–2020 and The European Vac-
cine Action Plan 2015–2020 [5,6]. Over 30000 cases of measles were registered in Europe in
2015, including including 368 in Serbia [7].
The Republic of Serbia (Serbia) is a country located in Southeast Europe with a population
of about 7 million inhabitants and a birth cohort size of about 70 000 [8]. Surveillance based
on the WHO measles case definition was implemented in 2009 [9] and relies on the 22 Insti-
tutes of Public Health (IPH)-governmental organizations involved in communicable disease
prevention and control, the National Reference Laboratory for measles (NRL) and health-care
workers (HCWs) at all levels of health care. Mandatory, free-of-charge vaccination against
measles was introduced in 1971, given as a single dose of monovalent vaccine at the age of 12–
15 months. In 1986, a single dose of combined measles-mumps (MM) vaccine was introduced.
As of 1993, measles-mumps-rubella (MMR) vaccine replaced the MM vaccine. A two-dose
MMR schedule was introduced in 1996 with the second dose given at 12 years of age. Since
2006, the second dose is scheduled at the age of seven years [10].
Between 2001 and 2011, vaccination coverage for the first dose of MMR was continuously
above 95%, while the coverage for the second dose ranged from 84% to 98% [11]. In the period
2012–2015, coverage dropped to<95% for both doses due to frequent vaccine shortages and
anti-vaccination movements [11, 12]. Between 2000 and 2006, measles incidence was below
0.5/100.000 inhabitants [11]. In 2007, an outbreak of measles in the Autonomous Province of
Vojvodina (Vojvodina) in the North of the country affected mostly unvaccinated Roma chil-
dren between 1 and 14 years of age [13]. Until 2010 only sporadic cases were recorded. In 2010
and 2011, a measles outbreak occurred in Southeast Serbia and affected at least 363 people,
mostly unvaccinated children up to 4 years of age [14]. After 2011, only two sporadic measles
cases were recorded until end of 2014, when yet another resurgence of measles was observed.
This manuscript summarizes the main characteristics of the measles resurgence in Serbia in
2014–2015, identifies its causes and discusses interventions to prevent future epidemics.
Materials and methods
Ethics statement
The investigation of the measles resurgence in Serbia was done in the frame of national public
health surveillance. Sample collection for laboratory diagnosis was part of standard patient
management and required only oral informed patient consent. Data on suspected measles
cases were reported by the physicians to the IPH on a daily basis. Access to patient data was
restricted to employees directly involved in measles diagnosis and reporting.
Case definition and classification
A suspected measles case is defined as a patient with fever and a maculopapular rash and at
least one of the following three symptoms: cough, coryza or conjunctivitis. Final classifications
of measles cases as clinically compatible, epidemiologically linked or laboratory confirmed
cases as well as definition by origin (endemic, imported, import-related, unknown) were done
according to the WHO criteria [15]. Two or more laboratory confirmed cases which are tem-
porally related and epidemiologically and/or virologically linked, were considered as an out-
break [15].
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Data sources
Epidemiological data were obtained from the surveillance database of the IPH of Serbia, Bel-
grade and the IPH of Vojvodina, Novi Sad. Data originate from the mandatory notification
forms, epidemiological questionnaires and medical records and include demographic data
including occupation, residence and ethnicity, date of symptom onset, clinical characteristics,
hospitalization status, case confirmation method, measles vaccination status, travel and con-
tact history, potential epidemiological links and disease outcome. Final case classifications
were done by the IPH of Serbia, after completion of the laboratory and epidemiological
investigations.
Sample collection, laboratory testing and phylogenetic analysis
Clinical samples were normally collected by trained laboratory technicians upon request of an
epidemiologist as part of routine, case-based surveillance. The epidemiologist also decided
which specimens were taken, based on a case evaluation and according the algorithm for speci-
men collection [9]. A large number of suspected cases required the limitation of laboratory
testing to cases from new locations and without epidemiological links to laboratory-confirmed
cases. Due to the various reasons such as refusal and unavailability of follow-up, samples could
not be collected from all suspected cases without an epidemiological link. Sera for the detection
of measles-specific IgM antibodies were collected within 3–28 days after rash onset, while
nose/throat swabs for detection of viral RNA were obtained within seven days of rash onset. In
the laboratories of the IPHs, different commercial ELISA kits were used for IgM antibody test-
ing and only the NRL performed viral RNA detection by PCR, as described before [14]. In
total, 420 sera (including two follow up sera from one patient) and 213 nose/throat swabs were
collected between November 2014 and December 2015.
To assess whether most patients had primary contact with measles virus, IgG avidity was
checked for 57 IgM positive sera using a commercial ELISA kit (Euroimmun, Lübeck, Ger-
many). Serum samples were conveniently selected for avidity testing with a similar distribution
in respect to age, sex, and vaccination status as the total laboratory confirmed sera specimens.
The samples had been collected from 28 females and 29 males between 1 and 54 years of age.
Thirteen patients were unvaccinated, 38 had an unknown vaccination status, and 6 patients
were vaccinated, 4 of them with a single dose and 2 with two doses of MMR. All PCR positive
nose/throat swabs were used to attempt measles virus genotyping.
The swabs had been collected from patients aged�1 year up to 50 years of age. Initial
sequence analysis was done using SeqScape Software v2.5 (Applied Biosystems, USA), followed
by BioEdit version 7.0.9.0 [16]. Phylogenetic trees were generated based on the Kimura
2-parameter model, the Neighbor-Joining algorithm and 450 nucleotides (nt) of the measles
virus nucleoprotein using MEGA6 software [17]. The most recent reference sequences [18], all
named strains of genotype D8 and some BLAST (basic local alignment search tool that finds
regions of similarity between biological sequences) fits of Serbian sequences were included in
the analysis. The sequences from Serbia were named according to WHO nomenclature with
location as well as rash onset date by epidemiological week and year [19] and are available on
MeaNS [20] and on GenBank under accession numbers MH249631-MH249767.
Results
Descriptive epidemiology
Between November 2014 and December 2015, a resurgence of measles was registered in Serbia.
The first cases occurred in the northern province Vojvodina (Fig 1).
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The index case was a student of the University of Novi Sad, originating from Bileća, Repub-
lic of Srpska, Bosnia and Herzegovina (B&H), where he was in contact with a family member
with measles. The first notified and laboratory confirmed case was another student, who had
contact with the index case in Novi Sad, eight days before onset of symptoms (MVs/Novi Sad.
SRB/48.14, Fig 2).
The outbreak originating from this case affected mostly student residences in South Bačka
district and comprised 64 measles cases until end of March 2015. A one-and-a-half-year-old
unvaccinated Roma child was the first case of measles in the Srem district, Vojvodina (MVs/
Sremska_Mitrovica.SRB/49.14, Fig 2). According to the epidemiological data, he lived with his
family in a home for asylum seekers in Berlin, Germany, in November 2014, where he was
exposed to asylum seekers with measles. Seven days after returning to Serbia, the child experi-
enced measles symptoms, but there were no secondary cases. Between January and April 2015,
two districts of Vojvodina experienced outbreaks (North Bačka and Middle Banat) with overall
18 patients, mainly students who travelled to B&H (e.g. MVs/Subotica.SRB/3.15, Fig 2).
Between February and April 2015 measles cases accumulated in the resident population of
Vojvodina (e.g. MVs/Novi Sad.SRB/12.15, MVs/Zrenjanin.SRB/7.15, MVs/Sremska Mitro-
vica.SRB/14.15, Fig 2) without confirmed epidemiological link to the students. Overall 93 cases
(4.8/100 000 inhabitants) were notified in Vojvodina until the end of the outbreak (April
2015). Nearly half of the patients (n = 41, 44.1%) were citizens of B&H with temporary resi-
dence in Vojvodina.
Between November 2014 and April 2015, a measles resurgence with 90 registered cases
took place in Belgrade city. The first case was identified during the investigation of an epidemi-
ologically related case (MVs/Beograd.SRB/46.14, genotype D9, Fig 2) and had been travelling
through Asia for three consecutive weeks before falling ill on the last day of the trip. Two other
measles cases, both of them citizens of B&H, were considered as imported from B&H based on
epidemiological data. These cases caused import-related cases (e.g. MVs/Beograd.SRB/47.14,
Fig 1. Incidence rates of measles per 100 000 inhabitants in the four major administrative regions in Serbia, 2014–2015. Measles outbreaks
occurred in four regions of Serbia (Vojvodina province, Belgrade city, Central and West Serbia and Southeast Serbia).
https://doi.org/10.1371/journal.pone.0224009.g001
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Fig 2. D8 cluster of a phylogenetic tree constructed based on 450 nucleotides of the measles virus N gene using the
Kimura 2-parameter model and the Neighbor-Joining algorithm. The Serbian sequences are marked with grey dots
if they were from 2014 and with black dots if observed in 2015. For the 2014 sequences the strain detected at the
earliest time point was selected, for 2015 the one found at the latest time point. Numbers in brackets indicate identical
sequences from the same year and location. Triangles mark genotype D8 named strains with GenBank accession
numbers and diamonds highlight identical BLAST fits of Serbian sequences.
https://doi.org/10.1371/journal.pone.0224009.g002
Measles resurgence in Serbia, 2014-2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0224009 October 17, 2019 5 / 14
Fig 2) and according to epidemiological data were the probable source of the majority of sub-
sequent measles cases in the outbreak in Belgrade. Another measles outbreak in Belgrade with
three hospital-acquired cases lasted from June 18th to July 21th 2015. The index case (MVs/Bel-
grade.SRB/26.15, identical to “Rostov on Don” variant shown in Fig 2) was a two-year-old
child, who had been hospitalized at the Niš Children’s Clinic (Southeast Serbia) seven days
before admission to the hospital in Belgrade. This case was the source of infection for two
mothers staying with their children in the same hospital (e.g. MVs/Belgrade.SRB/30.15, Fig 2).
An outbreak of measles in Southeast Serbia with 199 cases affected primarily Nišava district
(86% of all cases) and spread among residents within schools, kindergartens, companies and
healthcare institutions. For the cases occurring in a Roma settlement (e.g. MVs/Leskovac.SRB/
15.15, Fig 2), a probable epidemiological link to Germany was identified. A total of 25 measles
cases, including six hospitalized patients and 12 health-care workers (HCWs), were registered
during an outbreak at the Niš Children’s Clinic between March 30 and June 10, 2015.
Overall, 420 (67.3%) out of 624 suspected cases were classified as measles. In 2014, 37 mea-
sles cases were notified in Serbia, resulting in an incidence of 0.5/100 000 inhabitants. The rest
of the cases occurred in 2015 (n = 383; incidence 5.4/100 000). The highest incidence was reg-
istered in Southeast (12.7/100 000) and the lowest in Central and West Serbia (1.9/100 000 citi-
zens) (Fig 1). The overall measles incidence during the outbreak period was 5.8/100 000
population. The peak in the number of measles cases was observed in January and February
2015 in Vojvodina, Belgrade city, Central and West Serbia and in April 2015 in Southeast Ser-
bia (Fig 3). The measles resurgence ended in December 2015 and no cases occurred until
October 2016.
Eleven measles cases were classified as imported, most of them (n = 9) from Republic
of Srpska, B&H. All of these 11 cases were laboratory confirmed and for eight of them
sequence data were obtained (MVs/Novi Sad.SRB/49.14/2, MVs/Novi_Sad.SRB/2.15, MVs/
Sremska_Mitrovica.SRB/49.14, MVs/Sabac.SRB/49.14, Fig 2; MVs/Novi Sad.SRB/49.14/3,
MVs/Novi Sad.SRB/51.14/2, MVs/Beograd.SRB/49.14, identical to “Rostov on Don” variant
shown in Fig 2; MVs/Novi_Sad.SRB/3.15/10, identical to MVs/Novi_Sad.SRB/2.15 shown in
Fig 2). These cases have resulted in at least 22 import-related cases. For the majority of cases in
this resurgence (n = 377, 89.8%) no source of infection could be established and they were
considered as endemic. Data for the classification of ten cases were lacking, resulting in an
unknown importation status (Table 1).
Overall 42 employees of 17 healthcare institutions (12 physicians, 20 nurses, two lab workers,
two medical students and six technical-supportive employees) became infected with measles.
Six HCWs with measles were born before 1971 and therefore not vaccinated. A total of 28
HCWs were born between 1971 and 1984 (they should have received one dose of vaccine) of
which eight had documented vaccination, two were unvaccinated, and the rest had an unknown
vaccination status. Eight HCWs were born after 1984, but only two of them were fully vacci-
nated, one was unvaccinated and the remaining patients had an unknown vaccination status.
The majority of infected HCWs acquired measles while working in a hospital (n = 29). At least
22 secondary cases occurred, most of them (n = 13) among hospitalized patients.
Characteristics of patients
Similar numbers of males and females (51.3% vs 48.7%) were affected. The youngest patient
was two months and the oldest 56 years old (median 28 years). Most patients were adults�20
years (n = 285; 67.9%). Almost one third of the cases (n = 124; 29.5%) were children aged 0–14
years. The age-specific incidence rates ranged from 2.5 (age 15–19 years) to 25.9 (age 0–4
years) per 100 000 population (Table 2)
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For more than half of the patients (n = 223; 53.1%) medical records were available showing
that 5.4% had been vaccinated with two doses and 17.0% with one dose of measles virus-con-
taining vaccine. Of the 77.6% (n = 173/223) unvaccinated patients, many were children�4
years of age (n = 80; 46.2%) and adults�20 years of age (n = 57; 32.9%). Patients with
unknown vaccination status (n = 197/420; 46.9%) were mostly adults (99%)(Table 2). At least
80 Roma were affected including 58 children aged�14 years (70% unvaccinated and 27.6%
with unknown vaccination status). The majority (93.7%) of Roma patients were residents of
Southeast Serbia.
A total of 138 patients (32.9%) were hospitalized. The reasons were measles-related compli-
cations (30.4% of hospitalized patients) or as a precautionary measure because of severe
Fig 3. Number of measles cases by month of notification and residence in Serbia, 2014–2015.
https://doi.org/10.1371/journal.pone.0224009.g003
Table 1. Number of measles cases by case confirmation method and origin of infection in Serbia, 2014–2015.
Measles cases Laboratory-confirmed Epidemiologically linked Total
Imported 11 0 11
Import-related 22 0 22
Endemic 302 75 377
Unknown 8 2 10
Total 343 77 420
https://doi.org/10.1371/journal.pone.0224009.t001
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disease. Excluding diarrhoea (n = 40, 29.0%), and malnutrition (n = 7; 5.1%), serious compli-
cations were reported in at least 42 hospitalized patients including pneumonia (n = 37; 26.8%),
pleural effusion (n = 2; 1.4%) and erosion of the cornea (n = 1; 0.7%). Two cases of encephalitis
associated with measles were registered, but there were no fatalities. Complications were
mostly notified in patients above 30 years and below 4 years of age (45.2 and 23.8% respec-
tively). The majority of them were unvaccinated (n = 20; 47.6%) or with unknown vaccination
status (n = 19; 45.2%) and only three adult patients were vaccinated with one dose of vaccine
more than 30 years ago (range 33–37 years).
Laboratory findings
Out of 624 suspected measles cases, 526 (84.3%) were tested and 343 of them (65.2%) were lab-
oratory confirmed, 198 by serology, 80 by PCR and 65 by both methods (Table 3).
A total of 37 sera showed low avidity, suggesting a recent primary infection, while the
remaining 20 sera had high avidity measles IgG antibodies, indicating previous contact with
measles wild-type or vaccine virus. All patients with low avidity were either unvaccinated
(n = 12) or with unknown vaccination status (n = 25). Of the patients with high avidity, 13 had
an unknown vaccination status, one patient was registered as unvaccinated, and the remaining
six patients were vaccinated, four of them with a single dose at least 23 years (range 23–38
years) before infection and two with two doses with the second one given 9 and 10 years before
infection.
Virus characterization
Overall, 137 measles virus sequences were obtained. All sequences except for the one related to
an importation from Asia (MVs/Beograd.SRB/46.14, genotype D9, Fig 2) belonged to geno-
type D8 and 14 different sequence variants differing by 1–4 nucleotides were identified. Ten
sequence variants were detected only once. In addition, there were 4 groups, each with
Table 2. Age specific incidence and number of measles cases in Serbia 2014–2015 by age group and vaccination status.
Doses of measles containing vaccine Age groups
0–4 n(%) 5–9 n(%) 10–14 n(%) 15–19 n(%) 20–29 n(%) �30 n(%) Total n(%)
0 dose 80(93.0) 26(96.3) 5(45.5) 5(45.5) 30(38.0) 27(13.1) 173(41.2)
1 dose 6(7.0) 1(3.7) 6(54.5) 4(36.4) 2(2.5) 19(9.2) 38(9.0)
2 or more doses 0(0.0) 0(0.0) 0(0.0) 0(0.0) 7(8.9) 5(2.4) 12(2.9)
Unknown 0(0.0) 0(0.0) 0(0.0) 2(18.1) 40(50.6) 155(75.3) 197(46.9)
Total number of cases 86(100.0) 27(100.0) 11(100.0) 11(100.0) 79(100.0) 206(100.0) 420(100.0)
Age specific incidencea 25.9 8.6 3.2 2.5 8.9 4.2 5.8
aper 100.000 population
https://doi.org/10.1371/journal.pone.0224009.t002
Table 3. Laboratory results during the measles resurgence in Serbia, 2014–2015.
Sample No. of patients Serum IgM Nose-throat swab (PCR)
Positive Negative Equivocal Positive Negative
Swab 106 / / / 80 26
Serum and swab 107 65 40 2 65 42
Serum 313 198 96 19 / /
Total 526 263 136 21 145 68
https://doi.org/10.1371/journal.pone.0224009.t003
Measles resurgence in Serbia, 2014-2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0224009 October 17, 2019 8 / 14
identical sequences. These groups comprised 2, 6, 12 and 106 sequences, respectively, and the
last group contained the major strain found in 9 different locations in the country. Identical
sequences had been reported from other countries including Austria, Croatia, Italy and Slove-
nia. The main outbreak variant was detected in the country during a time period covering at
least 35 weeks (epidemiological week 48 in 2014 until 30 in 2015). Sequences identical to the
ones in the group of six had been found before in Germany and in B&H (Fig 2) and epidemio-
logical information suggests a link to Germany. All other 12 sequence variants were according
to BLAST analysis so far only detected in Serbia, suggesting that they evolved during the mea-
sles resurgence.
Outbreak control measures
The public health authorities of Serbia conducted outbreak response immunization (ORI) of
unvaccinated or incompletely vaccinated children aged up to 14 years in 18 districts/74 munic-
ipalities where MMR coverage for the first and/or second dose was less than 95%. Overall
10824 unvaccinated children and 8560 incompletely vaccinated children were identified.
Despite ORI, MMR vaccination coverage remained <90% for both doses in 2014 and 2015
(84.0% and 85.8% for the first and 87.5% and 89.2% for the second dose) [10,11]. Patients were
isolated and treated at home or in the hospital as appropriate. People who had been exposed to
measles were placed under medical surveillance while children aged�14 years exposed within
72 hours were offered MMR vaccination. Measures proposed for the prevention of measles
spread in healthcare settings were distributed to healthcare institutions. All HCWs who suf-
fered from measles were immediately excluded from work.
Discussion
The present report describes a thorough retrospective analysis of the measles resurgence in
Serbia in 2014/15, thereby providing important information on how to counteract the future
epidemics. Measles was initially introduced by and spread among citizens of B&H with tempo-
rary residence in Serbia. Most of them were students born in B&H during the war or post-war
period (1992–1998) who were unvaccinated or had an unknown vaccination status. At the
time of the introduction, a large measles outbreak caused mainly by the “Rostov on Don” vari-
ant of genotype D8 was ongoing in B&H [21,22]. The same virus variant was also responsible
for most cases linked to the 2014/2015 measles resurgence in Serbia (77.4%, n = 106 of the 137
sequences obtained in total) and to an outbreak in Germany [23–25], where an unvaccinated
Roma child from Srem (MVs/Sremska_Mitrovica.SRB/49.14, Fig 2) was probably exposed.
The fact that no genotype D4 strains, responsible for the 2010/2011 outbreak [14], were found,
suggests that measles virus transmission had been interrupted in Serbia after the previous
epidemic.
The territorial variations in measles incidence could be related to differences in the quality
of surveillance, past MMR coverage rates, presence of traveler communities and influence of
vaccine objectors, especially among HCWs [26,27]. In the North of the country, mostly adults
suffered from measles, probably reflecting low vaccination coverage and single dose vaccina-
tion policies in the years following vaccine introduction (e.g. 84–94% in Vojvodina between
1971–1982) [28]. The high incidence of measles among unvaccinated children�4 years in
Southeast Serbia was related to the lowest first dose MMR coverage rates in Serbia between
2012 and 2014 recorded in the Nišava district (68.3, 70.3 and 53.8%) [11,12].
The Romani ethnic population (colloquially known as Roma), constitute one of the largest
minorities in Serbia [8]. Traditionally low MMR vaccine coverage rates in Roma children
resulted in recurrent oubreaks in Roma settlements [13,14]. A supplementary immunization
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activity (SIA) after the measles outbreak in 2010–2011 failed to vaccinate vulnerable Roma in
Southeast Serbia. In 2014, MMR coverage among a representative number of Roma children
was 63.3%, compared to 85.8% national coverage [29]. Insufficient awareness of vaccination
benefits, vaccine safety concerns, poor access of Roma children to health care, particularly in
high poverty settlements as well as poor planning of physician visits and low compliance with
vaccination policies contributed to the re-emergence of measles in Roma communities in
2015. It is therefore essential to provide information about the benefits of vaccination and to
address the reasons for the hesitancy with the help of Roma mediators before SIA are done
[29]. The overall low success of the SIA was probably related to a lack of staff in healthcare ser-
vices, poor promotion of the vaccination campaigns and inadequate cooperation of healthcare
providers and local authorities [11,12].
Overall 24 measles cases below 1 year were not eligible for vaccination at the time of infec-
tion while patients aged 1–14 years were not vaccinated due to vaccine inaccessibility or paren-
tal refusal of vaccination. On average, only 79.1% (range 69.9% in 2014 to 85.9% in 2011) of all
children eligible for the first dose of vaccine between 2011 and 2014 were vaccinated at the rec-
ommended age of 12–15 months, suggesting that a large number of young children remained
unprotected [11,12]. A number of adult patients (63/285; 22.1%) were born before vaccine
introduction in 1971.
The proportion of affected adults�20 years increased during the last three major measles
resurgences in Serbia in 2007, 2010/11 and 2014/15 (37%, 45.1% and 67.9%, respectively)
[30,31], suggesting the urgent need for conducting SIA among adults. Vaccination should not
only be offered to women susceptible to rubella planning to become pregnant and people aged
�18 years [32,33], but to susceptible adults of both genders beyond the age of 18. During the
2014/2015 measles resurgence, 88.3% of patients were adults >20 and children�4 years of
age, who are more prone to severe measles and complications [34], resulting in a relatively
high hospitalization rate.
Measles surveillance needs to be strengthened in Serbia, since many cases in the 2014/2015
resurgence were classified as endemic only because the link to importations could not be estab-
lished and for several of the transmission chains, the index case was missed and countermea-
sures were launched too late. Another problem identified during our investigation was the lack
of vaccination records in almost half of the patients (46.9%), mostly adults, making it more dif-
ficult to evaluate the contribution of non-vaccination versus vaccine failures to the measles
resurgence. Further strategies should be evaluated by public health authorities regarding SIA
in adults with largely unknown vaccination status. Special considerations of the vaccination
algorithm of adults in relation to age and vaccination/susceptibility status should follow after
careful evaluation of feasibility and cost-effectiveness. A well-functioning national vaccination
information system would also strongly support effective public health countermeasures.
Because of the suboptimal surveillance system and the lack of vaccination records, an IgG anti-
body prevalence study would be of great help to identify susceptible population groups for tar-
geted SIA [35]. In addition, it would be helpful to capture the reasons for non-vaccination in
the context of vaccination coverage surveys to develop strategies to strengthen vaccination
coverage in Serbia. Since only patients who were seeking treatment were recorded, the true
number of measles cases in 2014/2015 was probably underestimated.
About 10% of all notified cases in this resurgence occurred among HCWs, who infected
patients, other employees and close contacts. Since measles infection of hospitalized patients
poses a high risk of severe disease and fatal outcome [36,37], MMR vaccination of susceptible
HCWs was recommended in the outbreak setting, but compliance was low. Mandatory MMR
vaccination for all susceptible HCWs born in 1971 or later was originally scheduled for 2020,
but since a substantial number of HCWs acquired measles in the current outbreak, MMR
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vaccination of susceptible HCWs in high-risk departments has been enabled recently [32,33].
All HCWs without documentation of vaccination with two doses of measles containing vac-
cine or laboratory evidence of measles or immunity are obliged to get vaccinated with two
doses of MMR separated by at least 28 days. If records of only one dose of vaccine are available,
an additional dose of MMR is required [32,33].
Measles IgG avidity testing in conjunction with appropriate epidemiological data is a useful
diagnostic tool to detect vaccine failures [38]. Measles in a previously vaccinated patient can be
classified as a primary vaccine failure (PVF) if low-avidity antibodies are detected [39]. In our
study, low avidity IgG results were obtained in patients who were either unvaccinated or had
an unknown vaccination status, suggesting rather primary contact with measles virus than
PVF. Secondary vaccine failure (SVF), on the other hand, results in patients with high avidity
measles IgG antibodies. More than one third of the patients tested had high-avidity measles
IgG antibodies (n = 20, 35%), suggesting that SVF did not only occur among the six patients
with documented vaccination, but probably also among patients with unknown vaccination
status.
Conclusions
Mainly adults and children�4 years were affected during the measles resurgence in Serbia in
2014–2015 causing a relatively high hospitalization rate. The growing number of adult patients
suggests an urgent need to conduct SIA targeting all susceptible adults irrespective of age. In
particular, susceptible HCWs need to be vaccinated to prevent further outbreaks in healthcare
settings. Since Serbia recently experienced another large measles resurgence [40], efficient
implementation of control measures including ORI is essential. The comprehensive investiga-
tion of the 2014/2015 measles resurgence and the identified problems and immunization gaps
will contribute to decisions about appropriate countermeasures to stop the future measles
resurgences in Serbia.
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